In March, two biotechnology companies were given the greenlight by the Food and Drug Administration, or FDA, to conduct ...

A biotech company recently announced that it's implanted another pig kidney into a human recipient. Here's what to know.

Asia's first gene-edited pig kidney transplant patient has maintained stable kidney function for more than 30 days after ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...

The success of the team at Jikei University School of Medicine in Tokyo marks a key step toward clinical studies involving ...

Australian researchers are poised to become the first in the world to take pancreatic islet cells from genetically modified ...

Privately-held Colossal first gained fame in 2022 when it announced its goal to bring the woolly mammoth back to life - ...

The company has pitched its gene-editing technology as a way to develop lucrative applications in health and biodiversity.

Colossal Biosciences, a Dallas-based biotech firm with a $10 billion valuation, has announced a new breakthrough in its ...

Colossal Biosciences of Dallas has announced a new breakthrough in its mission to resurrect extinct animals. The company said ...